Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.2K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of membrane structures regulating primary ciliogenesis by quantitative isotropic ultrastructure imaging.

Nature communications·2026
Same author

Combining multiplexed assays of variant effect for enhanced BRCA2 variant classification.

Nature communications·2026
Same author

Rare cancers research: Current state of knowledge and emerging opportunities for prevention and interception.

Journal of the National Cancer Institute·2026
Same author

A single BRCA2 BRC repeat supports viability while multiple repeats ensure resilience under stress.

bioRxiv : the preprint server for biology·2026
Same author

Yes, It Is Worth It: Consider Participant Experiences in the Design of Future Trials.

Cancer prevention research (Philadelphia, Pa.)·2026
Same author

Assessment of a Handheld Near-Infrared Light Device in Detecting Intracranial Hematomas in Mbarara, Uganda.

Neurosurgery·2025

Related Experiment Video

Updated: Nov 26, 2025

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

5.8K

A computational model for classification of BRCA2 variants using mouse embryonic stem cell-based functional assays.

Kajal Biswas1, Gary B Lipton2, Stacey Stauffer1

  • 1Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA.

NPJ Genomic Medicine
|December 9, 2020
PubMed
Summary

This study functionally characterized 88 BRCA2 variants using mouse embryonic stem cells and DNA damaging agents. A new computational model was developed to assess variant pathogenicity for hereditary breast and ovarian cancer risk assessment.

More Related Videos

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

14.9K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.4K

Related Experiment Videos

Last Updated: Nov 26, 2025

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

5.8K
Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

14.9K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.4K

Area of Science:

  • Genetics
  • Cancer Biology
  • Bioinformatics

Background:

  • Genetic testing identifies numerous BRCA2 variants of uncertain significance (VUS) impacting hereditary breast and ovarian cancer risk assessment.
  • Lack of familial and epidemiological data hinders accurate VUS classification.
  • Functional assays are crucial for determining the clinical impact of VUS.

Purpose of the Study:

  • To functionally characterize 88 BRCA2 variants, including novel ones, using a mouse embryonic stem cell (mESC)-based assay.
  • To develop and validate a computational model integrating multiple functional assays for improved VUS pathogenicity assessment.
  • To enhance risk assessment for hereditary breast and ovarian cancers by clarifying the functional impact of BRCA2 variants.

Main Methods:

  • Functional characterization of 88 BRCA2 variants in Brca2 null mESCs, assessing DNA repair rescue and sensitivity to DNA damaging agents (ionizing radiation, PARP inhibitor).
  • Analysis of BRCA2 variant impact on splicing.
  • Development of a novel computational platform integrating data from multiple functional assays for variant pathogenicity prediction.
  • Validation of computational models using known pathogenic and neutral BRCA2 variants.

Main Results:

  • Successful functional characterization of 88 BRCA2 variants, including previously uncharacterized ones, using mESC-based assays.
  • Development of a robust computational model that integrates data from multiple functional assays, outperforming single-assay models.
  • Demonstrated utility of the developed models in classifying VUS and variants with conflicting interpretations.
  • Validated models accurately predicted pathogenicity for known pathogenic and neutral BRCA2 variants.

Conclusions:

  • The study provides crucial functional data for 88 BRCA2 variants, aiding in the interpretation of VUS.
  • The novel computational platform offers a more accurate method for assessing BRCA2 variant pathogenicity.
  • This work improves risk stratification for individuals with hereditary breast and ovarian cancer syndromes.
  • The findings support clinical decision-making and genetic counseling for BRCA2-related cancer risk.